Tongtong Pan

Zhejiang Provincial Key Laboratory For Accurate Diagnosis And Treatment Of Chronic Liver Diseases
Wenzhou, 325000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

Retraction notice to "the molecular structure of SHISA5 protein and its novel role in primary biliary cholangitis: From single-cell RNA sequencing to biomarkers" [Int. J. Biol. Macromol. 296 (2025) 139775].

Retraction notice to "the molecular structure of SHISA5 protein and its novel role in primary biliary cholangitis: From single-cell RNA sequencing to biomarkers" [Int. J. Biol. Macromol. 296 (2025) 139775].

Journal: International journal of biological macromolecules

Published: August 21, 2026

Corrigendum to "Spatial confinement-enhanced CHA system based on tetrahedral DNA nanostructures for sensitive in situ mRNA analysis" [Talanta 306 (2026) 129764].

Corrigendum to "Spatial confinement-enhanced CHA system based on tetrahedral DNA nanostructures for sensitive in situ mRNA analysis" [Talanta 306 (2026) 129764].

Journal: Talanta

Published: June 10, 2026

Corrigendum to "Integrative multi-omics and experimental validation reveal UBE2C as a central hub gene and prognostic biomarker in hepatocellular carcinoma" [Int. Immunopharmacol. 183 (2026) 116866].

Corrigendum to "Integrative multi-omics and experimental validation reveal UBE2C as a central hub gene and prognostic biomarker in hepatocellular carcinoma" [Int. Immunopharmacol. 183 (2026) 116866].

Journal: International immunopharmacology

Published: June 05, 2026

Bile Acids as a Liver-Muscle Axis Mediator: Moving From Association to Intervention.

Bile Acids as a Liver-Muscle Axis Mediator: Moving From Association to Intervention.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: April 07, 2026

Spatial confinement-enhanced CHA system based on tetrahedral DNA nanostructures for sensitive in situ mRNA analysis.

Spatial confinement-enhanced CHA system based on tetrahedral DNA nanostructures for sensitive in situ mRNA analysis.

Journal: Talanta

Published: February 22, 2026

Integrative multi-omics and experimental validation reveal UBE2C as a central hub gene and prognostic biomarker in hepatocellular carcinoma.

Integrative multi-omics and experimental validation reveal UBE2C as a central hub gene and prognostic biomarker in hepatocellular carcinoma.

Journal: International immunopharmacology

Published: December 10, 2025

Unveiling novel macrophage-specific biomarkers in MASH through single-cell sequencing for diagnostic modeling.

Unveiling novel macrophage-specific biomarkers in MASH through single-cell sequencing for diagnostic modeling.

Journal: Journal of lipid research

Published: November 14, 2025

Clarifying residual drug effects and subgroup outcomes in TDF-to-BSV switch trials: Letter to the editor on "Switching to besifovir in patients with chronic hepatitis B receiving tenofovir disoproxil fumarate: A randomized trial".

Clarifying residual drug effects and subgroup outcomes in TDF-to-BSV switch trials: Letter to the editor on "Switching to besifovir in patients with chronic hepatitis B receiving tenofovir disoproxil fumarate: A randomized trial".

Journal: Clinical and molecular hepatology

Published: September 11, 2025

Exploring the Causal Relationship Between Gut Microbiota and Pulmonary Artery Hypertension: Insights From Mendelian Randomization.

Exploring the Causal Relationship Between Gut Microbiota and Pulmonary Artery Hypertension: Insights From Mendelian Randomization.

Journal: Journal of the American Heart Association

Published: March 13, 2025

The molecular structure of SHISA5 protein and its novel role in primary biliary cholangitis: From single-cell RNA sequencing to biomarkers.

The molecular structure of SHISA5 protein and its novel role in primary biliary cholangitis: From single-cell RNA sequencing to biomarkers.

Journal: International journal of biological macromolecules

Published: November 20, 2024

Letter to the Editor: Interpreting the 100% disease control rate of Sin-Bev-RT in HCC with PVTT.

Letter to the Editor: Interpreting the 100% disease control rate of Sin-Bev-RT in HCC with PVTT.

Journal: Hepatology (Baltimore, Md.)

Published: November 12, 2024

Repression of the ERRγ-CYP2E1 pathway by FGF4 mitigates alcohol-associated liver injury.

Repression of the ERRγ-CYP2E1 pathway by FGF4 mitigates alcohol-associated liver injury.

Journal: Hepatology (Baltimore, Md.)

Published: September 27, 2024

Showing 1-12 of 40

Last Updated: 09/26/2026